Provided by Tiger Fintech (Singapore) Pte. Ltd.

AbbVie

218.17
+3.881.81%
Volume:4.06M
Turnover:880.92M
Market Cap:385.15B
PE:91.28
High:218.66
Open:210.00
Low:209.20
Close:214.29
Loading ...

Why Investors Need to Take Advantage of These 2 Medical Stocks Now

Zacks
·
03 Feb

AbbVie price target raised to $220 from $218 at Raymond James

TIPRANKS
·
03 Feb

AbbVie Is Maintained at Buy by Guggenheim

Dow Jones
·
03 Feb

Wolfe Research Adjusts Price Target on AbbVie to $220 From $205, Keeps Outperform Rating

MT Newswires Live
·
03 Feb

AbbVie price target raised to $215 from $205 at Citi

TIPRANKS
·
03 Feb

Abbvie : Leerink Partners Raises Target Price to $210 From $206

THOMSON REUTERS
·
03 Feb

BUZZ-Street View: AbbVie's Skyrizi and Rinvoq drugs remain key drivers for long-term growth

Reuters
·
03 Feb

U.S. RESEARCH ROUNDUP-Abbvie, Comstock Resources, Sherwin-Williams

Reuters
·
03 Feb

Why AbbVie Inc. (ABBV) Is Among the Best Cancer Stocks to Buy According to Hedge Funds

Insider Monkey
·
03 Feb

Can AbbVie Inc.'s (NYSE:ABBV) ROE Continue To Surpass The Industry Average?

Simply Wall St.
·
02 Feb

AbbVie Reports Strong 2024 Growth Amid Challenges

TIPRANKS
·
02 Feb

AbbVie Inc (ABBV) Q4 2024 Earnings Call Highlights: Strong Revenue Growth and Strategic Outlook

GuruFocus.com
·
01 Feb

Post-Bell|Wall St Ends Lower as U.S. Preps Tariffs; Tesla up 1.1%; Quantum Computing Shares Gain with RGTI up 7%; Intel Falls 3%

Tiger Newspress
·
01 Feb

S&P 500 Gains and Losses Today: UGG Footwear Maker Deckers Outdoor Plunges on Weak Outlook

Investopedia
·
01 Feb

Equity Markets Retreat as Tariffs Loom

MT Newswires Live
·
01 Feb

US Equities Markets End Lower Friday as Markets Analyze Latest Inflation Reading, Corporate Earnings

MT Newswires Live
·
01 Feb